Compare WLKP & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLKP | CYRX |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 764.8M | 774.7M |
| IPO Year | 2014 | 2008 |
| Metric | WLKP | CYRX |
|---|---|---|
| Price | $21.38 | $16.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 35.1K | ★ 527.4K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.25% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,166,695,000.00 | $176,177,000.00 |
| Revenue This Year | $19.48 | $11.06 |
| Revenue Next Year | $5.24 | $8.45 |
| P/E Ratio | $15.30 | ★ N/A |
| Revenue Growth | ★ 2.71 | N/A |
| 52 Week Low | $17.75 | $7.61 |
| 52 Week High | $23.88 | $16.89 |
| Indicator | WLKP | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 65.07 |
| Support Level | $20.74 | $14.55 |
| Resistance Level | $22.26 | N/A |
| Average True Range (ATR) | 0.41 | 0.62 |
| MACD | 0.02 | 0.19 |
| Stochastic Oscillator | 42.86 | 98.61 |
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.